These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 20981809)

  • 1. Hepatitis C virus-associated polyarteritis nodosa.
    Saadoun D; Terrier B; Semoun O; Sene D; Maisonobe T; Musset L; Amoura Z; Rigon MR; Cacoub P
    Arthritis Care Res (Hoboken); 2011 Mar; 63(3):427-35. PubMed ID: 20981809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database.
    Pagnoux C; Seror R; Henegar C; Mahr A; Cohen P; Le Guern V; Bienvenu B; Mouthon L; Guillevin L;
    Arthritis Rheum; 2010 Feb; 62(2):616-26. PubMed ID: 20112401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of matrix metalloproteinases, proinflammatory cytokines, and oxidative stress-derived molecules in hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy.
    Saadoun D; Bieche I; Authier FJ; Laurendeau I; Jambou F; Piette JC; Vidaud M; Maisonobe T; Cacoub P
    Arthritis Rheum; 2007 Apr; 56(4):1315-24. PubMed ID: 17393409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years.
    Eleftheriou D; Dillon MJ; Tullus K; Marks SD; Pilkington CA; Roebuck DJ; Klein NJ; Brogan PA
    Arthritis Rheum; 2013 Sep; 65(9):2476-85. PubMed ID: 23754739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus.
    Sene D; Ghillani-Dalbin P; Thibault V; Guis L; Musset L; Duhaut P; Poynard T; Piette JC; Cacoub P
    J Rheumatol; 2004 Nov; 31(11):2199-206. PubMed ID: 15517633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia.
    Cacoub P; Renou C; Kerr G; Hüe S; Rosenthal E; Cohen P; Kaplanski G; Charlotte F; Thibault V; Ghillani P; Piette JC; Caillat-Zucman S
    Arthritis Rheum; 2001 Sep; 44(9):2118-24. PubMed ID: 11592376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia.
    Saadoun D; Sellam J; Ghillani-Dalbin P; Crecel R; Piette JC; Cacoub P
    Arch Intern Med; 2006 Oct; 166(19):2101-8. PubMed ID: 17060540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus.
    Saadoun D; Aaron L; Resche-Rigon M; Pialoux G; Piette JC; Cacoub P;
    AIDS; 2006 Apr; 20(6):871-7. PubMed ID: 16549971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.
    Gayraud M; Guillevin L; le Toumelin P; Cohen P; Lhote F; Casassus P; Jarrousse B;
    Arthritis Rheum; 2001 Mar; 44(3):666-75. PubMed ID: 11263782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy.
    Saadoun D; Bieche I; Maisonobe T; Asselah T; Laurendeau I; Piette JC; Vidaud M; Cacoub P
    Arthritis Rheum; 2005 Sep; 52(9):2917-25. PubMed ID: 16142759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic vasculitis in patients with hepatitis C.
    Cacoub P; Maisonobe T; Thibault V; Gatel A; Servan J; Musset L; Piette JC
    J Rheumatol; 2001 Jan; 28(1):109-18. PubMed ID: 11196510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality rate and outcome factors in mixed cryoglobulinaemia: the impact of hepatitis C virus.
    Della Rossa A; Tavoni A; D'Ascanio A; Catarsi E; Marchi F; Bencivelli W; Salvadori S; Migliorini P; Bombardieri S
    Scand J Rheumatol; 2010 Mar; 39(2):167-70. PubMed ID: 20337547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microscopic polyangiitis and polyarteritis nodosa: how and when do they start?
    Agard C; Mouthon L; Mahr A; Guillevin L
    Arthritis Rheum; 2003 Oct; 49(5):709-15. PubMed ID: 14558058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasculitides associated with malignancies: analysis of sixty patients.
    Fain O; Hamidou M; Cacoub P; Godeau B; Wechsler B; Pariès J; Stirnemann J; Morin AS; Gatfosse M; Hanslik T; Belmatoug N; Blétry O; Cevallos R; Delevaux I; Fisher E; Hayem G; Kaplan G; Le Hello C; Mouthon L; Larroche C; Lemaire V; Piette AM; Piette JC; Ponge T; Puechal X; Rossert J; Sarrot-Reynauld F; Sicard D; Ziza JM; Kahn MF; Guillevin L
    Arthritis Rheum; 2007 Dec; 57(8):1473-80. PubMed ID: 18050165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyarteritis nodosa in north India: clinical manifestations and outcomes.
    Sharma A; Pinto B; Dhooria A; Rathi M; Singhal M; Dhir V; Sharma K; Parkash M; Modi M; Vijayvergiya R; Sinha SK; Nada R; Minz RW; Singh S
    Int J Rheum Dis; 2017 Mar; 20(3):390-397. PubMed ID: 27990777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predominance of type 1 (Th1) cytokine production in the liver of patients with HCV-associated mixed cryoglobulinemia vasculitis.
    Saadoun D; Boyer O; Trébeden-Nègre H; Limal N; Bon-Durand V; Andreu M; Klatzmann D; Piette JC; Cacoub P
    J Hepatol; 2004 Dec; 41(6):1031-7. PubMed ID: 15582138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria.
    Takuma Y; Nouso K; Makino Y; Gotoh T; Toshikuni N; Morimoto Y; Shimomura H; Yamamoto H
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1417-24. PubMed ID: 21884248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
    Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
    Manousou P; Samonakis D; Cholongitas E; Patch D; O'Beirne J; Dhillon AP; Rolles K; McCormick A; Hayes P; Burroughs AK
    Liver Transpl; 2009 Dec; 15(12):1783-91. PubMed ID: 19938143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
    Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
    Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.